<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref012">
 <label>12</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Verma</surname>
   <given-names>V</given-names>
  </name>, 
  <name>
   <surname>Sprave</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Haque</surname>
   <given-names>W</given-names>
  </name>, 
  <name>
   <surname>Simone</surname>
   <given-names>CB</given-names>
   <suffix>2nd</suffix>
  </name>, 
  <name>
   <surname>Chang</surname>
   <given-names>JY</given-names>
  </name>, 
  <name>
   <surname>Welsh</surname>
   <given-names>JW</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors</article-title>. 
  <source>Journal for immunotherapy of cancer</source>. 
  <year>2018</year>;
  <volume>6</volume>(
  <issue>1</issue>):
  <fpage>128</fpage>
  <pub-id pub-id-type="doi">10.1186/s40425-018-0442-7</pub-id>
  <?supplied-pmid 30470252?>
  <pub-id pub-id-type="pmid">30470252</pub-id>
 </mixed-citation>
</ref>
